NPPA fixes retail price of 20 new drugs
The National Pharmaceutical Pricing Authority (NPPA) has announced retail price fixation of 20 new drugs based on the decision of its Authority meeting held on November 15, 2021. Out of the total new drugs for which the prices were fixed, 17 were combinations containing diabetes drug Dapagliflozin, which was patented by drug major AstraZeneca
NPPA Fixes Retail Price Of 20 New Drugs | 07/12/2021 | By Darshana | 211
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy